Abstract
Introduction: Refractory Status Epilepticus (RSE) is a serious medical emergency where the seizure does not subside despite conventional pharmacological treatment. The continuous presence of episodes lasting 24 hours or more is described as super-refractory status epilepticus (SRSE). This case report details the complex in teraphy management and explores a multidisciplinary approach.
Case presentation: A 32-year-old male with a history of focal epilepsy secondary to head trauma in childhood. Enters emergency with a RSE episode. Barbiturate coma, plasmapheresis and ketogenic diet were administered. The Magnetic Resonance Imaging revealed a lesion in the right fronto-temporo-insular cortex, areas of hypermetabolism on Positron Emission Tomography and continuous epileptiform activity on video-electroencephalogram. Palliative surgery was chosen, achieving successful resolution of the SRSE and Engel Scale IA classification at 14 months of follow up.
Discussion: The SRSE is a critical neurological event with a guarded prognosis and complex therapeutic options. Therapeutic options are described from anticonvulsants, immunotherapy and surgery. The surgical approach emerges as an effective option, especially in cases with structural injuries. Early identification and appropriate therapy are vital to prevent complications.
Conclusions: SRSE represents a critical challenge with a high burden of morbidity and mortality. However, epilepsy surgery shows promising results in the context of the structural brain cause responsible for epileptiform activity. The importance of early identification and palliative surgical management as a viable option is highlighted, improving the quality of life of patients.
References
Múnera CP, Lomlomdjian C, Solis P, Medel N, Seoane E, Kochen S. Crossed aphasia after right anterior temporal lobectomy: a case report. Epilepsy Behav. 2012;25(1):125-8. https://doi.org/10.1016/j.yebeh.2012.05.014
Cervenka MC, Hocker S, Koenig M, Bar B, Henry-Barron B, Kossoff EH, et al. Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus. Neurology. 2017;88(10):938-43. https://doi.org/10.1212/WNL.0000000000003690
Ruiz Cuero M, Varelas PN. Super-Refractory status epilepticus. Curr Neurol Neurosci Rep. 2015;15(11):74. https://doi.org/10.1007/s11910-015-0594-5
Lv RJ, Wang Q, Cui T, Zhu F, Shao XQ. Status epilepticus-related etiology, incidence and mortality: a meta-analysis. Epilepsy Res. 2017;136:12-7. https://doi.org/10.1016/j.eplepsyres.2017.07.006
Samanta D, Garrity L, Arya R. Refractory and super-refractory status epilepticus. Indian Pediatr. 2020;57(3):239-53. https://doi.org/10.1007/s13312-020-1759-0
Gaspard N, Foreman B, Judd LM, Brenton JN, Nathan BR, McCoy BM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013;54(8):1498-503. https://doi.org/10.1111/epi.12247
de Brito Sampaio LP. Ketogenic diet for epilepsy treatment. Arq Neuro-Psiquiatr. 2016;74(10):842-8. https://doi.org/10.1590/0004-282X20160116
Melvin JJ, Huntley Hardison H. Immunomodulatory treatments in epilepsy. Semin Pediatr Neurol. 2014;21(3):232-7. https://doi.org/10.1016/j.spen.2014.08.001
Trinka E, Brigo F. Neurostimulation in the treatment of refractory and super-refractory status epilepticus. Epilepsy Behav. 2019;101:106551. https://doi.org/10.1016/j.yebeh.2019.106551
Dibué-Adjei M, Brigo F, Yamamoto T, Vonck K, Trinka E. Vagus nerve stimulation in refractory and super-refractory status epilepticus - a systematic review. Brain Stimul. 2019;12(5):1101-10. https://doi.org/10.1016/j.brs.2019.05.011
Kirmani BF, Au K, Ayari L, John M, Shetty P, Delorenzo RJ. Super-refractory status epilepticus: prognosis and recent advances in management. Aging Dis. 2021;12(4):1097-119. https://doi.org/10.14336/AD.2021.0302
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.